Company: PSTV
Filing Date: 2025-06-09
Form Type: DRS
Source: 0000950123-25-005986
Chunk: 50

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-06-09
Form: DRS
Chunk 50
---
10.12

#  |     | First Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated January 26, 2017.                                                                 |     | 10-K                      |     | 001-34375   |     |   10.42 |     | 03/24/2017  |
| 10.13

#  |     | Second Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated February 6, 2020.                                                                |     | 10-K                      |     | 001-34375   |     |   10.25 |     | 03/30/2020  |
| 10.14

#  |     | Third Amendment to The Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated June 6, 2024.                                                                     |     | S-1                       |     | 333-280061  |     |   10.15 |     | 06/07/2024  |
| 10.15

#  |     | Form of Notice of Grant of Stock Option under the 2015 New Employee Incentive Plan.                                                                                      |     | S-8                       |     | 333-210211  |     |    99.5 |     | 03/15/2016  |
| 10.16

#  |     | Form of Stock Option Agreement under the 2015 New Employee Incentive Plan.                                                                                               |     | S-8                       |     | 333-210211  |     |    99.4 |     | 03/15/2016  |
| 10.17

#  |     | Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as amended and restated.                                                                                              |     | 8-K                       |     | 001-34375   |     |    10.1 |     | 05/17/2021  |
| 10.18

#  |     | Form of Notice of Grant and Stock Option Agreement under the 2020 Stock Incentive Plan.                                                                                  |     | 10-K                      |     | 001-34375   |     |   10.26 |     | 02/24/2022  |
II-7

Confidential Treatment Requested by